BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15451756)

  • 1. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 2. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators.
    Streitner F; Kuschyk J; Veltmann C; Mahl E; Dietrich C; Schimpf R; Doesch C; Streitner I; Wolpert C; Borggrefe M
    Europace; 2011 May; 13(5):668-74. PubMed ID: 21156679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillators--for whom?
    Connolly SJ
    Lancet; 1998 Aug; 352(9125):338-40. PubMed ID: 9717916
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.
    Sheldon R; O'Brien BJ; Blackhouse G; Goeree R; Mitchell B; Klein G; Roberts RS; Gent M; Connolly SJ
    Circulation; 2001 Oct; 104(14):1622-6. PubMed ID: 11581139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 9. [Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required].
    Jensen SM; Kesek M
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3236, 3238-41. PubMed ID: 20101834
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of elderly recipients of implantable cardioverter defibrillators.
    Grimm W; Stula A; Sharkova J; Alter P; Maisch B
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S134-8. PubMed ID: 17302690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
    Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
    Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients.
    Nisam S; Kaye SA; Mower MM; Hull M
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):142-7. PubMed ID: 7724388
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators.
    Ng GA; Rae AP; Rankin AC; Cobbe SM
    Scott Med J; 1996 Apr; 41(2):35-7. PubMed ID: 8735498
    [No Abstract]   [Full Text] [Related]  

  • 16. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriate use of the implantable cardioverter defibrillator: a Canadian perspective. Canadian Working Group on Cardiac Pacing.
    Yee R; Connolly SJ; Gillis AM
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):1-4. PubMed ID: 9990594
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy success and survival in patients with valvular heart disease and implantable cardioverter defibrillator.
    Rosenheck S; Weiss A; Sharon Z
    Int J Cardiol; 2010 Sep; 144(1):103-4. PubMed ID: 19193458
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
    Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
    Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.